Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. [PDF]
Requena G +12 more
europepmc +1 more source
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL. [PDF]
Sethi S +4 more
europepmc +1 more source
Real-World Impact of Initial Dual Bronchodilation on Exercise Physiological Response and Health-Related Quality of Life in Newly Diagnosed, Treatment-Naïve Chronic Obstructive Pulmonary Disease. [PDF]
Dimiene I +7 more
europepmc +1 more source
Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis. [PDF]
Miravitlles M +6 more
europepmc +1 more source
EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS. [PDF]
Buhl R +6 more
europepmc +1 more source
The efficacy of pulmonary rehabilitation on cognitive functions in patients with chronic obstructive pulmonary disease: systematic review. [PDF]
Alkandari S +3 more
europepmc +1 more source
Proactive surveillance of foodborne bioactives by integrated dietary exposure and urinary excretion assessment. [PDF]
Park H, Son J.
europepmc +1 more source
Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study. [PDF]
Posthuma R +5 more
europepmc +1 more source
Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US. [PDF]
Shaikh A +6 more
europepmc +1 more source
Pulmonary Rehabilitation in Primary Care: Functional and Emotional Impact in a Patient with COPD: A Case Report. [PDF]
Esteves V, Gonçalves SD.
europepmc +1 more source

